A detailed history of Tiger Global (Tiger Global Management LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Tiger Global Management LLC holds 930,000 shares of LLY stock, worth $722 Million. This represents 4.02% of its overall portfolio holdings.

Number of Shares
930,000
Previous 890,000 4.49%
Holding current value
$722 Million
Previous $692 Million 21.61%
% of portfolio
4.02%
Previous 3.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $29 Million - $36.4 Million
40,000 Added 4.49%
930,000 $842 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $15.3 Million - $18 Million
-29,100 Reduced 3.17%
890,000 $519 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $84.8 Million - $117 Million
195,000 Added 26.93%
919,100 $494 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $254 Million - $340 Million
724,100 New
724,100 $340 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Tiger Global's Portfolio

Track Tiger Global Portfolio

Follow Tiger Global (Tiger Global Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Global Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiger Global Management LLC and Tiger Global with notifications on news.